Onfi 10 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB25FJT04
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,684
Award facts
- Contract value 100% obligated
- $11,683.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Onfil 10 mg tablets (100-count units) valued at $11,683.85 under a firm fixed-price contract type. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the supply of a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive portfolio of pharmaceutical distributions. The company's federal contracting demonstrates consistent capability in fulfilling diverse medical supply requirements, ranging from specialty medications and generic drugs to vaccines and medical devices across multiple therapeutic domains. This delivery order exemplifies the company's role in supporting Defense Health Agency operations and broader military healthcare logistics through the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FJT04?
SPE2DB25FJT04 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FJT04 worth?
The government has obligated $11,684 on SPE2DB25FJT04.
Is contract SPE2DB25FJT04 an order under another contract?
Yes. SPE2DB25FJT04 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJT04 competed?
The extent of competition for SPE2DB25FJT04 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award